SPIVA India Explained: What the Scorecard Measures and How to Read It

SPIVA, short for S&P Indices Versus Active, is a periodic research scorecard published by S&P Dow Jones Indices that measures what proportion of actively managed funds in a category outperformed a designated benchmark index over defined periods. The India edition applies the same framework to Indian mutual fund categories. It is best understood as a methodology, not a headline: what makes it worth reading is the set of design choices it makes about universe, benchmark, costs and survivorship.

This article describes how the scorecard is constructed and how to read it without over-reading it. It deliberately does not quote figures or year-specific results, because those change with every edition and the point here is the method.

What the scorecard is actually measuring

At its core, SPIVA answers one question per category and per horizon: of the funds that were in this category at the start of the period, what percentage produced a return below the designated benchmark index over that period?

Notice the shape of that question. It is a count, not an average. It tells you about the spread of outcomes across a group of funds, not about how much any fund won or lost by. A category where most funds trail the index by a hair and a category where most funds trail it badly can produce a similar underperformance percentage, which is why the accompanying return tables matter as much as the headline count.

The scorecard also reports the average return of the fund category alongside the benchmark’s return, in two forms. The equal-weighted average treats every fund the same and answers “what did a randomly chosen fund do”. The asset-weighted average weights each fund by the money in it and answers “what did the average rupee experience”. Those two numbers are answering different questions, and reading only one is a common mistake.

The methodology choices that give it weight

Four decisions separate SPIVA from an ordinary performance table.

A designated benchmark per category. Rather than allowing each fund to be compared against a benchmark of its own choosing, the scorecard assigns one index per category. This removes a well known source of flattery, where a fund whose real exposure sits outside its stated category is measured against an index it does not resemble. The general problem is covered in benchmark selection for portfolios.

Total return indices. The comparison uses index returns that reinvest dividends, so the index is not artificially handicapped by ignoring the income its constituents pay. A fund receives those dividends, so the benchmark should count them too. See total return index vs price index for why this distinction moves results.

Returns net of fees. Fund returns are taken after the expense ratio has been deducted, because that is what an investor actually receives. The index has no fee, which is part of the point: the scorecard is measuring the bar an investor faces, not a theoretical gross comparison. The compounding effect of that fee layer is set out in expense ratio impact on returns.

Survivorship correction. This is the design choice that does the most quiet work. Funds that perform poorly are frequently merged into other schemes or wound up. A study that measures only the funds still alive today is measuring a universe from which the worst results have already been removed. SPIVA fixes the universe at the start of each period and counts funds that closed or merged during it as not having beaten the benchmark, so the comparison reflects the choice set an investor actually faced at the start. The same failure mode wrecks strategy testing, as described in survivorship bias in backtests.

Alongside the underperformance counts, the scorecard typically reports a survivorship rate, showing what share of the funds that existed at the start of a period still existed at the end, and a style consistency measure, showing what share stayed in the same category rather than drifting into another. Both are informative in their own right. A category with a low survivorship rate is telling you something about turnover in the product shelf, not just about performance.

Horizons, and why the long ones matter more

SPIVA reports across multiple horizons, typically one year through ten years or longer, ending on a common date. The short horizons are the least informative. Over one year, the result is dominated by whichever style, sector or size segment happened to lead the market, and by where the window happened to start and stop.

Longer horizons compress that noise, but they introduce their own bias: only funds with a full track record over the horizon can be measured, and the universe shrinks as the horizon lengthens. The survivorship correction is what keeps that shrinkage from turning into a flattering selection.

The related Persistence Scorecard, published separately by the same index provider, asks a different and arguably more useful question: of the funds that ranked in the top quartile in one period, how many stayed in the top quartile in subsequent periods? Persistence is the bridge between “some funds beat the index” and “you could have identified them in advance”, and it is the harder test.

How to read a scorecard honestly

A few reading habits keep the conclusions proportionate.

• Read the category, not the aggregate. Categories differ in market depth, benchmark composition and constraints. A result in one category is not evidence about another.
• Read both weightings. The equal-weighted and asset-weighted numbers can diverge meaningfully, and the divergence itself is information about whether larger or smaller funds fared better.
• Read the end date. Every edition ends on a specific date. A period ending after a sharp move in one segment of the market can flatter or punish an entire category of funds for reasons unrelated to skill. Rolling returns exist because single start and end dates are fragile.
• Read the survivorship and style-consistency columns. They often say more about the category than the headline count.
• Treat it as a distribution statement. “A majority of funds trailed the index” and “no fund can beat the index” are entirely different claims, and only the first is supported.

What SPIVA does not tell you

This is the section that matters most, and it is where the scorecard is most often misused.

• It does not name funds. By design, it reports aggregates. It cannot be used to identify a specific scheme as good or bad, and nothing in it constitutes a view on any fund.
• It does not predict. A past distribution of outcomes is not a forecast of the next one. The Persistence Scorecard exists precisely because the leap from “past” to “next” is not automatic.
• It does not measure investor returns. It measures fund returns between two fixed dates. Real investors enter and exit at other dates, so what they actually earned can differ from what the fund earned, in either direction.
• It does not account for tax, exit loads or transaction costs to the investor. The comparison is net of the fund’s expense ratio, not net of everything an investor pays. The index is also not directly investable: replicating it costs something, which the raw index return does not reflect.
• It is sensitive to category definition. Scheme categorisation determines which funds are grouped together and which index they are matched to. Reasonable people can disagree about the mapping, and a different mapping can shift results.
• It says nothing about risk taken. Two funds can reach the same return with very different volatility, drawdown and concentration. A pure return comparison ignores that, which is why risk-adjusted returns and tracking error belong alongside it.
• It covers mutual funds, not every vehicle. Portfolio management services, alternative investment funds and stock baskets sit outside the scope and are structured differently, as set out in PMS vs mutual funds vs stock baskets.

Read with those boundaries in place, SPIVA is a useful piece of infrastructure: a consistently constructed, survivorship-corrected, benchmark-matched view of how a category of funds fared against the index it is measured on. Read as a verdict on any individual fund, or as a forecast, it is being asked to carry weight its methodology was never built to bear.

Related reading

• Portfolio metrics explained: the hub for how fund and portfolio performance is measured.
• Why active funds underperform benchmarks: the structural mechanics behind the pattern SPIVA observes.
• Active share explained: how far a fund’s holdings actually depart from its index.
• Total return index vs price index: why the choice of index series changes the comparison.
• Best mutual fund research tools in India: what a fund research stack needs to answer these questions.

This article is educational. Altys Labs is not a registered research analyst or investment adviser, and nothing here is investment advice or a recommendation to buy, sell, or hold any security.